STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs

LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has announced that its board of directors has appointed Warren Foust, president and chief operating officer, and Deborah Andrews, chief financial officer, as interim co-chief executive officers, effective February 1, 2026. Foust and Andrews will work together with the other members of the executive leadership team, with support and guidance from the board of directors, as they lead the company and manage its day-to-day operations, the announcement said.